APA (7th ed.) Citation

Alsugair, A., Fathima, S., Aperna, F., Gangat, N., & Tefferi, A. Sodium-glucose co-transporter-2 inhibitor treatment-associated changes in hemoglobin level in anemic patients with myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms. Ferrata Storti Foundation.

Chicago Style (17th ed.) Citation

Alsugair, Ali, Saubia Fathima, Fnu Aperna, Naseema Gangat, and Ayalew Tefferi. Sodium-glucose Co-transporter-2 Inhibitor Treatment-associated Changes in Hemoglobin Level in Anemic Patients with Myelodysplastic Syndromes or Myelodysplastic/myeloproliferative Neoplasms. Ferrata Storti Foundation.

MLA (9th ed.) Citation

Alsugair, Ali, et al. Sodium-glucose Co-transporter-2 Inhibitor Treatment-associated Changes in Hemoglobin Level in Anemic Patients with Myelodysplastic Syndromes or Myelodysplastic/myeloproliferative Neoplasms. Ferrata Storti Foundation.